United States

Apricus Biosciences Inc (APRI.OQ)

APRI.OQ on NASDAQ Stock Exchange Capital Market

22 Jul 2016
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for APRI.OQ


Apricus Biosciences, Inc. is a pharmaceutical company, which develops pharmaceutical products. The Company primarily focuses on the development and commercialization of products and product candidates in the areas of urology and rheumatology. The Company's drug delivery technology is a permeation enhancer called NexACT. The... (more)


Beta: 0.59
Market Cap(Mil.): $20.62
Shares Outstanding(Mil.): 61.81
Dividend: --
Yield (%): --


  APRI.OQ Industry Sector
P/E (TTM): -- 36.15 37.05
EPS (TTM): -0.30 -- --
ROI: -312.86 15.11 14.35
ROE: -- 16.17 15.56

BRIEF-Apricus Biosciences expands existing partnership with Ferring Pharmaceuticals

* Apricus biosciences inc says apricus and sandoz agree to mutually terminate license agreement

7:31am EDT

BRIEF-Apricus Biosciences enters into common stock purchase agreement with Aspire Capital

* Apricus Biosciences enters into common stock purchase agreement with Aspire Capital

Jul 06 2016

BRIEF-Apricus Biosciences reports Q1 loss per share of $0.05

* To continue to reduce operating expenses with goal of achieving reductions of about 30% in 2016, 60% in 2017 compared to 2015

May 09 2016


Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
Provider : ValuEngine, Inc.
Provider : S&P Capital IQ Quantitative Report
Provider : Reuters Investment Profile
Provider : New Constructs, LLC

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.